Bosentan

Bosentan in the Treatment of Giant Cell Arteritis

Effect of Bosentan in Scleroderma Renal Crisis

Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer

A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood

Endothelin-1 Receptor Blockade in Resistant Hypertension

Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea

A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

FUTURE 3 Study Extension

Combination Therapy in Pulmonary Arterial Hypertension

The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension

Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension

Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)

Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443

Persistent Pulmonary Hypertension of the Newborn

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)

Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Bosentan in Children With Pulmonary Arterial Hypertension Extension Study

Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)

Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology